Matches 1 - 50 out of 384 1 2 3 4 5 6 7 8 >


Match Document Document Title
8163751 Acylated indanyl amines and their use as pharmaceuticals  
The present invention relates to acylated indanyl amines according to the general formula (I) wherein R1-R4 have the meanings given in the description, A is CH2, CHOH or CH—(C1-C3-alkyl), B is C...
8129432 Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor  
Compounds, methods, uses, compositions, kits and packages for the treatment of imbalance between bone resorption and bone formation, based on uses of 4-phenyl-2 propionamidotetralin (4-P-PDOT) and...
8128905 Stabilized uncoated particles of reversed liquid crystalline phase materials  
Uncoated particles of reversed cubic phase or reversed hexagonal phase material containing an active disposed within are provided. The uncoated particles have an ionic charge that is sufficient to...
8119180 Method for maintaining freshness of fruits and vegetables  
A process and a composition to extend the freshness of fruits and vegetables are disclosed. The method comprises treating fresh fruit or vegetable structures with a solution comprising organic...
8097655 Methods for concomitant administration of colchicine and macrolide antibiotics  
Methods for concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin, are disclosed. Such methods reduce the dangers commonly associated with...
8093297 Methods for concomitant administration of colchicine and a second active agent  
Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly...
8093296 Methods for concomitant administration of colchicine and macrolide antibiotics  
Methods for concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin, are disclosed. Such methods reduce the dangers commonly associated with...
8093298 Methods for concomitant administration of colchicine and macrolide antibiotics  
Methods for concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin, are disclosed. Such methods reduce the dangers commonly associated with...
8048449 Mouth dissolving pharmaceutical composition and process for preparing the same  
Disclosed herein is a orally disintegrating and/or dissolving oral pharmaceutical composition, comprising one or more active pharmaceutical ingredients, one or more fillers having particle size of...
8039515 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Methods for concomitant administration of colchicine and macrolide antibiotics  
Methods for concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin, are disclosed. Such methods reduce the dangers commonly associated with...
8039516 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Methods for concomitant administration of colchicine and macrolide antibiotics  
Methods for concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin, are disclosed. Such methods reduce the dangers commonly associated with...
8003700 Colchicine solid complex; methods of making; and methods of use thereof  
Disclosed are new colchicine solid complexes, methods of making the solid complexes as well as formulation prepared therefrom and uses thereof.
8003617 Methods of treating diabetes mellitus  
The invention provides methods of treating a diabetic subject comprising administering a glucosylceramide synthase inhibitor to the subject.
7981938 Colchicine compositions and methods  
Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such...
7981930 Compositions and kits for treating influenza  
Kits comprising an M2 inhibitor selected from amantadine and rimantadine; ribavirin, and a neuraminidase inhibitor (NAi) in an amount that is antivirally effective in the combination, an oral...
7964647 Colchicine compositions and methods  
Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such...
7964648 Methods for concomitant administration of colchicine and a second active agent  
Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly...
7915269 Methods for concomitant administration of colchicine and a second active agent  
Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly...
7906519 Methods for concomitant administration of colchicine and a second active agent  
Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly...
7897645 Herpesvirus-derived therapeutic agent for pain  
A therapeutic agent for treatment of herpes virus-derived pain which comprises (±)-[2-[4-(3-ethoxy-2-hydroxy-propoxy) phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonate represented by the ...
7867523 Pharmaceutical composition  
A pharmaceutical composition for the treatment of colds and influenza. The pharmaceutical composition is a mixture of: acetaminophen, diphenhydramine, dextromethorphan, arabinogalactan, vitamin C,...
7858660 Compositions and kits for treating influenza  
Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.
7820718 Combinations of ceramide and chemotherapeutic agents for inducing cell death and uses thereof in treating cancer  
This invention provides a method for increasing apoptosis in tumor cells and a method of decreasing a size of a tumor, said methods comprising contacting the tumor cells with: a) an effective...
7820681 Methods for concomitant administration of colchicine and a second active agent  
Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly...
7749526 Vermin-repellant compositions and compounds  
Compounds of formula (I) are described for deterring vermin, wherein R is unbranched or branched C1-C15 alkyl, which is unsubstituted or substituted by halogen, cyano or nitro; R1 and R2 are...
7736626 HFA supension formulations containing an anticholinergic  
The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of...
7736627 HFA suspension formulations containing an anticholinergic  
The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of...
7714025 Modified chalcone compounds as antimitotic agents  
Antimitotic agents comprising a modified chalcone or modified chalcone derivative are disclosed. The modified chalcone or modified chalcone derivative compounds are of the general formula...
RE41278 N-acetyl aldosamines and related N-acetyl compounds, and their topical use  
Compositions comprising N-acetyl-aldosamines, N-acetylamino acids, and related N-acetyl compounds are useful to alleviate or improve various cosmetic conditions and dermatological disorders,...
7691871 Multivitamin syrup for children or young adults  
The invention relates to an improved pharmaceutical or dietary composition in form of an aqueous syrup, consisting essentially of (a) vitamins recommended for consumption by children or young...
7655700 Transgenic mouse model and methods for treatment of neuro muscular disease by interfering with androgen-androgen receptor interaction in skeletal muscles  
The present invention describes a transgenic mouse susceptible to neuromuscular disease. The present invention also includes methods for treatment of neuromuscular diseases by interfering with...
7619004 Methods for concomitant administration of colchicine and macrolide antibiotics  
Methods for concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin or erythromycin, are disclosed. Such methods reduce the dangers commonly...
7550488 Application methods to rapidly alter disease and injury states using molecular transport of B6  
The present invention discloses methods of application employing B5/B6 vitamins in molecular transport creams or gels to deliver B6 in a high dose to bring about therapeutic ways in human or mammal...
7435429 Zinc salt compositions for the prevention of dermal and mucosal irritation  
The present invention provides for compositions and methods that may offer protection from irritants, as well as antimicrobial protection. Preferred embodiments of the invention include topical...
7432302 Composition containing polyamine transport inhibitor and use thereof  
Proliferative cutaneous disease states or conditions are treated by administering a polyamine transport inhibitor R-X-L-polyamine wherein R is a straight or branched C10-50 saturated or unsaturated...
7351692 Method and composition for potentiating the antipyretic action of a nonopioid analgesic  
A composition and method of treating fever, and optionally treating pain, is disclosed. The composition and method utilize a nonopioid analgesic and an endothelin antagonist as active agents to...
7311894 HFA suspension formulations containing an anticholinergic  
The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of...
7265155 Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound  
Preparations and extracts of valerian, as well as isovaleramide, isovaleric acid, and certain structurally related compounds, exhibit clinically significant pharmacological properties that...
7199153 Pharmaceutical composition comprising paracetamol and niflumic acid  
A formulation is described comprising paracetamol, niflumic acid or a pharmaceutically acceptable salt or ester thereof and a pharmaceutically acceptable excipient.
7141238 Compositions for reducing UV-induced inhibition of collagen biosynthesis in human skin  
Exposure of human skin to ultraviolet (UV) radiation from the sun not only induces the production of enzymes (matrix metalloproteinases) that degrade collagen, but also inhibits the synthesis of...
7101572 Taste masked aqueous liquid pharmaceutical composition  
A substantially taste masked liquid pharmaceutical composition containing a pharmaceutically effective amount of an unpleasant tasting drug dissolved or dispersed in an aqueous excipient base, said...
RE39221 Composition comprising a tramadol material and acetaminophen and its use  
This invention relates to a composition comprising a tramadol material and acetaminophen, and its use. As used herein tramadol refers to various forms of tramadol. The compositions are...
6964963 Preparation of 4-amino-1-naphthol ethers  
The present invention describes a process for preparing 4-amino-1-naphthol ethers which is characterized in that naphthol ethers are first prepared from 1-naphthols, the former are then converted...
6919072 Methods and compositions for reducing collagen loss due to chronological aging in human skin  
Chronological aging of human skin can be delayed with the topical application of an MMP inhibitor, preferably a retinoid (an indirect MMP inhbitor); retinoids also normalize procollagen...
RE38761 Styryl compounds which inhibit EGF receptor protein tyrosine kinase  
A method of inhibiting cell proliferation in a patient suffering from such disorder comprising administering to said patient an effective amount of a composition comprising, in admixture with a...
6828328 Analgesic combination of muscarinic agonists  
This invention relates to the combination of muscarinic agonists with narcotic analgesics, non-steroidal anti-inflammatory drugs or other analgesic drugs and to their use as antinociception (pain...
6821999 Methods for inhibiting the production of TSST-1  
The present invention relates to inhibiting the production of TSST-1 using absorbent products and non-absorbent products comprising an additive, as well as methods for inhibiting such production....
6803367 Substance for inducing apoptosis  
A substance for inducing apoptosis represented by specific formulae. A pharmaceutical composition which can be used for an anticancer agent containing said substance.
6767925 Sprayable analgesic composition and method of use  
A sprayable analgesic composition containing an analgesic which is absorbed into the bloodstream through the buccal mucosa and a pharmacologically acceptable liquid carrier.
6730329 Zinc containing compositions for anti-viral use  
One aspect of the invention relates to anti-viral composition containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients such as at least one...
Matches 1 - 50 out of 384 1 2 3 4 5 6 7 8 >